Showing 1 - 10 of 14
Many studies investigate the relationship between R&D expenditures as an input and patents as an intermediate product or output of a knowledge production function. We suggest that the productivity of research in patent production functions has been underestimated in the literature, as scholars...
Persistent link: https://www.econbiz.de/10003728577
The theoretical discussion concerning the question whether the incumbent or the (potential) entrant invests more into R&D has attracted considerable interest. This paper reports the results of an empirical study on this question using data of about 3500 German firms over the years 1992 to 1995....
Persistent link: https://www.econbiz.de/10011444512
variables the motives for innovation expenditures are also taken into account. We differentiate between firms which intend to …
Persistent link: https://www.econbiz.de/10010297441
Many studies investigate the relationship between R&D expenditures as an input and patents as an intermediate product or output of a knowledge production function. We suggest that the productivity of research in patent production functions has been underestimated in the literature, as scholars...
Persistent link: https://www.econbiz.de/10010298057
Many studies investigate the relationship between R&D expenditures as an input and patents as an intermediate product or output of a knowledge production function. We suggest that the productivity of research in patent production functions has been underestimated in the literature, as scholars...
Persistent link: https://www.econbiz.de/10014215973
Persistent link: https://www.econbiz.de/10003916156
Persistent link: https://www.econbiz.de/10008662658
For decades, the US public and private sectors have committed substantial resources towards cancer research, but the societal payoff has not been well-understood. We quantify the value of recent gains in cancer survival, and analyze the distribution of value among various stakeholders. Between...
Persistent link: https://www.econbiz.de/10012940684
For decades, the US public and private sectors have committed substantial resources towards cancer research, but the societal payoff has not been well-understood. We quantify the value of recent gains in cancer survival, and analyze the distribution of value among various stakeholders. Between...
Persistent link: https://www.econbiz.de/10012463075
The theoretical discussion concerning the question whether the incumbent or the (potential) entrant invests more into R&D has attracted considerable interest. This paper reports the results of an empirical study on this question using data of about 3500 German firms over the years 1992 to 1995....
Persistent link: https://www.econbiz.de/10013428313